C12R 2001/56
Streptomyces lavendulae
C12R2001/56 (Streptomyces lavendulae) appears on 11 US grants and 0 published applications in this corpus.
Search patents in C12R- Granted patents
- 11
- Published applications
- 0
- Assignees
- 5
- Inventors
- 36
- Latest grant
- 16 Jan 1996
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 2 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Method for producing aclacinomycins A, B, Y using Strepomyces lavendofoliae DKRS16 Jan 1996US 5,484,712 ADongkook Pharmaceutical Co., Ltd.
- S. lavendofoliae DKRS cell culture producing anti-tumor aclacinomycins A, B, Y and aglycones21 Nov 1995US 5,468,637 ADongkook Pharmaceutical Co., Ltd.
- Process for producing a transglutaminase derived from streptomyces12 Oct 1993US 5,252,469 AAmano Pharmaceutical Co., Ltd.
- Microbial preparation of 13.beta.-13-deoxy-22,23-dihydro avermectin-B1A/B1B aglycone6 Jul 1993US 5,225,338 AMerck & Co., Inc.
- Novel saframycin A derivatives and process for producing the same6 Jun 1989US 4,837,149 A
No published applications in this class yet.
Most cited
By later US patents
- Process for producing a transglutaminase derived from streptomyces32US 5,252,469 AAmano Pharmaceutical Co., Ltd. · 1993
- Physiologically active derivatives of esterastin13US 4,202,824 AZaidan Hojin Biseibutsu Kagaku Kenkyu Kai · 1980
- Antibiotics saframycins A, B, C, D and E and process for producing the same8US 4,248,863 A1981
- A40A Efrotomycin-like antibiotic in fermentation broth8US 4,264,607 AMerck & Co., Inc. · 1981
- Antibiotic saframycin S and process for producing the same7US 4,372,947 A1983